The role of opioid receptor phosphorylation and trafficking in adaptations to persistent opioid treatment

NeuroSignals

Volumn 14, Issue 6, 2006, Pages 290-302

  Johnson, Emma E ^a   Christie, MacDonald J ^a   Connor, Mark ^a  

^a ROYAL NORTH SHORE HOSPITAL   (Australia)

Author keywords

G Protein coupled receptor kinase; Morphine, chronic; Opioid receptor trafficking; Phosphorylation

Indexed keywords

MORPHINE; OPIATE; OPIATE RECEPTOR; PHOSPHOPROTEIN;

ADAPTATION; DESENSITIZATION; HUMAN; NERVE CELL; NONHUMAN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; QUALITATIVE ANALYSIS; QUANTITATIVE ANALYSIS; REVIEW; SIGNAL TRANSDUCTION;

ADAPTATION, PHYSIOLOGICAL; ANALGESICS, OPIOID; ANIMALS; HUMANS; PHOSPHORYLATION; RECEPTORS, OPIOID; SIGNAL TRANSDUCTION;

EID: 33745018099     PISSN: 1424862X     EISSN: None     Source Type: Journal    
DOI: 10.1159/000093044     Document Type: Review

References (96)

1. Hack SP, Vaughan CW, Christie MJ: Modulation of GABA release during morphine withdrawal in midbrain neurons in vitro. Neuropharmacology 2003;45:575-584.
2. Ossipov MH, Lai J, King T, Vanderah TW, Malan Jr TP, Hruby VJ, Porecca F: Antinociceptive and nociceptive actions of opioids. J Neurobiol 2004;61:126-148.
3. Bagley EE, Gerke MB, Vaughan CW, Hack SP, Christie MJ: GABA transporter currents activated by protein kinase A excite midbrain neurons during opioid withdrawal. Neuron 2005;45:433-445.
4. Bie B, Pan ZZ: Increased glutamate synaptic transmission in the nucleus raphe magnus neurons from morphine-tolerant rats. Mol Pain 2005;1:7. doi:10.1 186/1744-8069-1-7.
5. Saal D, Dong Y, Bonci A, Malenka RC: Drugs of abuse and stress trigger a common synaptic adaptation in dopamine neurons. Neuron 2003;37:577-582.
6. Williams JT, Christie MJ, Manzoni O: Cellular and synaptic adaptations mediating opioid dependence. Physiol Rev 2001;81:299-343.
7. Bailey CP, Connor M: Opioids: cellular mechanisms of tolerance and physical dependence. Curr Opin Pharmacol 2005;5:60-68.
8. Liu-Chen L-Y: Agonist-induced regulation and trafficking of κ opioid receptors. Life Sci 2004;75:511-536.
9. Varga EV, Navratilova E, Stropova D, Jambrosic J, Roeske WR, Yamamura HI: Agonist-specific regulation of the δ-opioid receptor. Life Sci 2004;76:599-612.
10. Gintzler AR, Chakrabarti S: Chronic morphine-induced plasticity among signalling molecules. Novartis Found Symp 2004;261:167-176.
11. Connor M, Christie MJ: Opioid receptor signalling mechanisms. Clin Exp Pharmacol Physiol 1999;26:493-499.
12. Maudsley S, Martin B, Luttrell LM: The origins of diversity and specificity in G protein-coupled receptor signaling. J Pharmacol Exp Ther 2005;314:485-494.
13. Segredo V, Burford NT, Lameh J, Sadee W: A constitutively internalizing and recycling mutant of the μ-opioid receptor. J Neurochem 1997;68:2395-2404.
14. 3): elevated basal signalling activity. Biochem J 2000;348:531-537.
15. Ingram S, Wilding TJ, McCleskey EW, Williams JT: Efficacy and kinetics of opioid action on acutely dissociated neurons. Mol Pharmacol 1997;52:136-143.
16. Connor M, Osborne P, Christie MJ: μ-Opioid receptor desensitization: is morphine different? Br J Pharmacol 2004;143:685-696.
17. 2 leads to K+-current desensitization. Nat Cell Biol 2000;2:507-514.
18. Nomura K, Reuveny E, Narahashi T: Opioid inhibition and desensitization of calcium channel currents in rat dorsal root ganglion neurons. J Pharmacol Exp Ther 1994;270:466-474.
19. Von Zastrow M, Svingos A, Haberstock-Debic, Evans C: Regulated endocytosis of opioid receptors: cellular mechanisms and proposed roles in physiological adaptation to opioid drugs. Curr Opin Neurobiol 2003;13:348-353.
20. Garzon J, Rodriguez-Munoz M, de la Torre-Madrid E, Sanchez-Blazquez P: Effector antagonism by the regulators of G protein signalling (RGS) proteins causes desensitization of mu-opioid receptors in the CNS. Psychopharmacology 2005;180:1-11.
21. Xie G-X, Palmer PP: RGS proteins: new players in the filed of opioid signaling and tolerance mechanisms. Anesth Analg 2005;100:1034-1042.
22. Garzon J, Rodriguez-Munoz M, Lopez-Fernando A, Sanchez-Blazquez P: Activation of μ-opioid receptors transfers control of Gα subunits to regulator of G-protein signalling RGS9-2. J Biol Chem 2005;280:8951-8960.
23. Zachariou V, Georgescu D, Sanchez N, Rahman Z, DiLeone R, Berton O, Neve RL, Sim-Selley LJ, Selley DE, Gold SJ, Nestler EJ: Essential role for RGS9 in opiate action. Proc Natl Acad Sci USA 2003;100:13656-13661.
24. Ferguson SSG: Evolving concepts in G protein-coupled receptor endocytosis: the role in receptor desensitisation and signaling. Pharmacol Rev 2001;53:1-24.
25. Daaka Y, Luttrell LM, Lefkowitz RJ: Switching of the coupling of the β2-adrenergic receptor to different G proteins by protein kinase A. Nature 1997;390:88-91.
26. Chavkin C, McLaughlin JP, Celver JP: Regulation of opioid receptor function by chronic agonist exposure: constitutive activity and desensitization. Mol Pharmacol 2001;60:20-25.
27. 375 residues within the carboxyl tail differentially regulates μ-opioid receptor internalization. J Biol Chem 2001;276:12744-12780.
28. Schulz S, Mayer D, Pfeiffer M, Stumm R, Koch T, Hollt V: Morphine induces terminal μ-opioid receptor desensitization by sustained phosphorylation of serine-375. EMBO J 2004;23:3282-3289.
29. Seibold A, Williams B, Huang Z-F, Friedman J, Moore RH, Knoll BJ, Clark RB: Localization of the sites mediating desensitization of the β2-adrenergic receptor by the GRK pathway. Mol Pharmacol 2000;58:1162-1173.
30. Trester-Zedlitz M, Burlingame A, Kobilka B, von Zastrow M: Mass spectrophotometric analysis of agonist effects on posttranslational modifications of the beta-2 adrenoceptor in mammalian cells. Biochemistry 2005;44:6133-6143.
31. Deng HB, Yu Y, Wang H, Guang W, Wang JB: Agonist-induced μ opioid receptor phosphorylation and functional desensitization in rat thalamus. Brain Res 2001;898:204-214.
32. Arden JR, Segredo V, Wang Z, Lameh J, Sadee W: Phosphorylation and agonist-specific intracellular trafficking of an epitope-tagged μ-opioid receptor expressed in HEK 293 cells. J Neurochem 1995;65:1636-1645.
33. Zhang L, Yu Y, Mackin S, Weight FF, Uhl GR, Wang JB: Differential μ opiate receptor phosphorylation and desensitization induced by agonists and phorbol esters. J Biol Chem 1996;271:11449-11454.
34. 2+-dependent. FEBS Lett 1996;386:53-57.
35. Yu Y, Zhang L, Yin X, Sun H, Uhl GR, Wang JB: μ-Opioid receptor phosphorylation, desensitization and ligand efficacy. J Biol Chem 1997;272:28869-28874.
36. Zhang J, Ferguson SSG, Barak LS, Bodduluri SR, Laporte SA, Law P-Y, Caron MG: Role for G protein-couple receptor kinase in agonist-specific regulation of μ-opioid receptor responsiveness. Proc Natl Acad Sci USA 1998;95:7157-7162.
37. Whistler JL, Chuang HH, Chu P, Jan LY, von Zastrow M: Functional dissociation of μ-opioid receptor signaling and endocytosis: implications for the biology of opiate tolerance and addiction. Neuron 1999;23:737-746.
38. 5-ol]enkephalin inhibition of adenylyl cyclase activity and agonist-induced μ-opioid receptor phosphorylation. J Biol Chem 1999;274:9207-9215.
39. Deng HB, Yu Y, Pak Y, O'Dowd BF, George SR. Surratt CK, Uhk GR, Wang JB: Role for the C-terminus in agonist-induced μ-opioid receptor phosphorylation and desensitization. Biochemistry 2000;39:5492-5499.
40. Koch T, Schulz S, Pfeiffer M, Klutzny M, Schroder H, Kahl E, Hollt V: C-terminal splice variants of the mouse μ-opioid receptor differ in morphine-induced internalization and receptor resensitization. J Biol Chem 2001;276:31408-31414.
41. 5-ol]enkephalin-μ-opioid receptor complexes demonstrated by cyclic AMP-dependent protein kinase phosphorylation. J Neurochem 1998;71:231-239.
42. McLaughlin JP, Chavkin C: Tyrosine phosphorylation of the μ-opioid receptor regulates intrinsic agonist efficacy. Mol Pharmacol 2001;59:1360-1368.
43. Kenski DM, Zhang C, von Zastrow M, Shokat KM: Chemical genetic engineering of G protein-coupled receptor kinase 2. J Biol Chem 2005;280:35051-35061.
44. Schulz R, Wehmeyer A, Schulz K: Opioid receptor types selectively cointernalize with G protein-coupled receptor kinases 2 and 3. J Pharmacol Exp Ther 2002;300:376-384.
45. Sadee W, Wang D, Bilsky EJ: Basal opioid receptor activity, neutral antagonists, and therapeutic opportunities. Life Sci 2005;76:1427-1437.
46. Strulovici B, Cerione R, Kilpatrick BF, Caron MG, Lefkowitz RJ: Direct demonstration of impaired functionality of a purified desensitized β-adrenergic receptor in an reconstituted system. Science 1984; 225: 837-840.
47. Gurevich VV, Dion SB, Onorato JJ, Ptasienski J, Kim CM, Sterne-Marr R, Hosey MM, Benovic JL: Arrestin interactions with G protein-coupled receptors. J Biol Chem 1995;270:720-731.
48. Gurevich VV, Gurevich EV: The molecular acrobatics of arrestin activation. Trends Pharmacol Sci 2004;25:105-111.
49. Bailey CP, Kelley EP, Henderson G: Protein kinase C activation enhances morphine-induced rapid desensitization of μ-opioid receptors in mature rat locus ceruleus neurons. Mol Pharmacol 2004;66:1592-1598.
50. Terman GW, Jin W, Cheong Y-P, Lowe J, Caron MG, Lefkowitz RJ, Chavkin C: G-protein receptor kinase 3 (GRK3) influences opioid analgesic tolerance but not opioid withdrawal. Br J Pharmacol 2004;141:55-64.
51. Oakley RH, Laporte SA, Holt JA, Caron MG, Barak LS: Differential affinities of visual arrestin, βarrestin1 and βarrestin2 for G protein-coupled receptors delineate two major classes of receptors. J Biol Chem 2000;275:17201-17210.
52. Bushell T, Endoh T, Simen AA, Ren D, Bindokas VP, Miller RJ: Molecular components of tolerance to opiates in single hippocampal neurons. Mol Pharmacol 2002;61:55-64.
53. Bohn LM, Dykstra LA, Lefkowitz RJ Caron MG, Barak LS: Relative opioid efficacy is determined by the complements of the G protein-coupled receptor desensitization machinery. Mol Pharmacol 2004;66:106-112.
54. Bohn LM, Lefkowitz RJ, Gainetdinov RR, Peppel K, Caron MG, Lin, FT: Enhanced morphine analgesia in mice lacking β-arrestin 2. Science 1999;286:2495-2498.
55. Bohn LM, Gainetdinov RR, Lin F, Lefkowitz RJ, Caron, MG: μ-Opioid receptor desensitization by β-arrestin-2 determines morphine tolerance but not dependence. Nature 2000;408:720-723.
56. Bohn LM, Lefkowitz RJ, Caron MG: Differential mechanisms of morphine antinociceptive tolerance revealed in βarrestin-2 knockout mice. J Neurosci 2002;22:10494-10500.
57. Sternini C, Spann M, Anton B, Keith Jr DE, Bunnet NW, von Zastrow M, Evans C, Brecha NC: Agonist selective endocytosis of μ-opioid receptor by neurons in vivo. Proc Natl Acad Sci USA 1996;93:9421-9426.
58. Trafton JA, Abbadie C, Marek K, Basbaum AI: Postsynaptic signaling via the μ-opioid receptor: responses of dorsal horn neurons to exogenous opioids and noxious stimulation. J Neurosci 2000;20:8578-8584.
59. He L, Fong J, von Zastrow M, Whistler JL: Regulation of opioid receptor trafficking and morphine tolerance by receptor oligomerization. Cell 2002;108:271-282.
60. Lee M-C, Cahill CM, Vincent J-P, Beaudet A: Internalization and trafficking of opioid receptor ligands in rat cortical neurons. Synapse 2002;43:102-111.
61. Keith DE, Murray SR, Zaki PA, Chu PC, Lissin DV, Kang L, Evans CJ, von Zastrow M: Morphine activates opioid receptors without causing their rapid internalization. J Biol Chem 1996;271:19021-19024.
62. Keith DE, Anton B, Murray SR, Zaki PA, Chu PC, Lissin DV, Monteillet-Agius G, Stewart PL, Evans CJ, von Zastrow M: μ-Opioid receptor internalization: opiate drugs have differential effects on a conserved endocytic mechanism in vitro and the mammalian brain. Mol Pharmacol 1998;53:377-384.
63. Borgland SL, Connor M, Osborne PB, Furness JB, Christie MJ: Opioid agonists have different efficacy profiles for G protein activation, rapid desensitization and endocytosis of mu-opioid receptors. J Biol Chem 2003;278:18776-18784.
64. Celver J, Xu M, Jin W, Lowe J, Chavkin C: Distinct domains of the μ-opioid receptor control uncoupling and internalization. Mol Pharmacol 2004;65:528-537.
65. Haberstock-Debic H, Kim K-A, Yu YJ, von Zastrow M: Morphine promotes rapid, arrestin-dependent endocytosis of μ-opioid receptors in striatal neurons. J Neurosci 2005;25:7847-7857.
66. Haberstock-Debic H, Wein M, Barrot M, Colago EEO, Rahman Z, Neve RL, Pickel VM, Nestler EJ, von Zastrow M, Svingos AL: Morphine acutely regulates opioid receptor trafficking selectively in dendrites of nucleus accumbens neurons. J Neurosci 2003;23:4324-4332.
67. Koch T, Schulz S, Schroder H, Wolf R, Raulf E, Hollt V: Carboxyl-terminal splicing of the rat μ-opioid receptor modulates agonist-mediated internalization and receptor resensitization. J Biol Chem 1998;273:13652-13667.
68. Tanowitz M, von Zastrow M: A novel endocytic recycling signal that distinguishes the membrane trafficking of naturally occurring opioid receptors. J Biol Chem 2003;278:45978-45986.
69. Koch T, Widera A, Bartzsch K, Schulz S, Brandenburg L-O, Wundrack N, Beyer A, Grecksch G, Hollt V: Receptor endocytosis counteracts the development of tolerance. Mol Pharmacol 2005;67:280-287.
70. Finn AK, Whistler JL: Endocytosis of the mu opioid receptor reduces tolerance and a cellular hallmark of withdrawal. Neuron 2001;32:829-839.
71. Dang V, Williams JT: Morphine-induced μ-opioid receptor desensitization. Mol Pharmacol 2005;68:1127-1132.
72. Bailey CP, Couch D, Johnson E, Griffiths K, Kelly E, Henderson G: μ-Opioid receptor desensitization in mature rat neurons: lack of interaction between DAMGO and morphine. J Neurosci 2003;23:10515-10520.
73. Blanchet C, Sollini M, Luscher C: Two distinct forms of desensitization of G-protein coupled inwardly rectifying potassium currents evoked by alkaloid and peptide μ-opioid receptor agonists. Mol Cell Neurosci 2003;24:517-523.
74. Christie MJ, Williams JT, North RA: Cellular mechanisms of opioid tolerance: studies in single brain neurons. Mol Pharmacol 1987;32:633-638.
75. Connor M, Borgland SL, Christie MJ: Continued morphine modulation of calcium channel currents in acutely isolated locus coeruleus neurons from morphine-dependent rats. Br J Pharmacol 1999;128:1561-1569.
76. Dang V, Williams JT: Chronic morphine treatment reduces recovery from desensitization. J Neurosci 2004;24:7699-7706.
77. Bagley EE, Chieng BCH, Christie MJ, Connor M: Opioid tolerance in periaqueductal gray mouse neurons isolated from mice chronically treated with morphine. Br J Pharmacol 2005;146:68-76.
78. A inhibition of bed nucleus of the stria terminalis neurons projecting to the ventral tegmental area. J Neurosci 2004;8198-8204.
79. 35S]-GTPγS autoradiography in rat brain. J Neurosci 1996;16:2684-2692.
80. Sim-Selley LJ, Selley DE, Vogt LJ, Childers SR, Martin TJ: Chronic heroin self-administration desensitizes μ opioid receptor-activated G-proteins in specific regions of rat brain. J Neurosci 2000;20:4555-4562.
81. 35S]thio]-triphosphate autoradiography in rat brain. Eur J Pharmacol 2002;446:43-51.
82. 5]enkephalin. J Neurosci 2001;21:3715-3720.
83. 5]enkephalin. J Biol Chem 2001;276:37779-37786.
84. Liu JG, Prather PL: Chronic exposure μ-opioid agonists produces constitutive activation of μ-opioid receptors in direct proportion to the efficacy of the agonist used for pretreatment. Mol Pharmacol 2001;60:53-62.
85. Wang D, Raehal KM, Lin ET, Lowery JJ, Kieffer BL, Bilsky EJ, Sadee W: Basal signaling activity of μ-opioid receptor in mouse brain: role in narcotic dependence. J Pharmacol Exp Ther 2004;308:612-620.
86. 5]enkephalin-induced internalization of the μ-opioid receptor in the spinal cord of morphine tolerant rats. Neuroscience 2004;125:541-543.
87. Drake CT, Aicher SA, Montalmant FL, Milner TA: Redistribution of mu-opioid receptors in C1 adrenergic neurons following chronic administration of morphine. Exp Neurol 2005;196:365-372.
88. Alvarez VA, Arttamangkul S, Dang V, Salem A, Whistler JL, von Zastrow M, Grandy DK, Williams JT: μ-Opioid receptors: ligand-dependent activation of potassium conductance, desensitization, and internalization. J Neurosci 2002;22:5769-5776.
89. Terwilliger RZ, Ortiz J, Guitart X, Nestler EJ: Chronic morphine administration increases β-adrenergic receptor kinase (βARK) levels in the rat locus coeruleus. J Neurochem 1994;63:1983-1986.
90. Patel MB, Patel CN, Rajashekara V, Yoburn BC: Opioid agonists differentially regulate μ-opioid receptor trafficking proteins in vivo. Mol Pharmacol 2002;62:1464-1470.
91. Lefkowitz RJ, Shenoy SK: Transduction of receptor signals by β-arrestins. Science 2005;308:512-517.
92. Werling LL, McMahon PN, Cox BM: Selective changes in μ opioid receptor properties induced by chronic morphine exposure. Proc Natl Acad Sci USA 1989;86:6393-6397.
93. Bhargava HN, Gulati A: Down-regulation of brain and spinal cord μ-opiate receptors in morphine tolerant-dependent rats. Eur J Pharmacol 1990;190:305-311.
94. Yoburn BC, Purohit V, Patel K, Zhang Q: Opioid agonist and antagonist treatment differentially regulates immunoreactive μ-opioid receptors and dynamin-2 in vivo. Eur J Pharmacol 2004;498:87-96.
95. Tao PL, Law PY, Loh HH: Decrease in delta and mu opioid receptor binding capacity in rat brain after chronic etorphine treatment. J Pharmacol Exp Ther 1987;240:809-816.
96. Diaz A, Ruiz F, Florez J, Hurle MA, Pazos A: Mu-opioid receptor regulation during opioid tolerance and supersensitivity in rat central nervous system. J Pharmacol Exp Ther 1995;274:1545-1551.